Pfizer Back To “Business As Normal”
For Immediate Release November 16, 2018 Contact: Lauren Blair (201) 213-5004… Read More
For Immediate Release November 16, 2018 Contact: Lauren Blair (201) 213-5004… Read More
For Immediate Release Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies. Read More
For Immediate ReleaseContact: Lauren Blair(201) [email protected]… Read More
Out-of-control drug prices was a prominent issue on the campaign trail. With… Read More
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement… Read More
CSRxP issued the following statement in response to the U.S. Department of… Read More
Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers &… Read More
Washington, D.C. – Today the Campaign for Sustainable Rx Pricing… Read More
CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In… Read More
Legislation Includes CSRxP-Supported Amendment Enabling HHS To Require… Read More
CSRxP spokesman Will Holley released the following statement in response to… Read More